Bernstein launches coverage of Canada’s Tilray, Cronos and Canopy Growth but stops short of any buy ratings

Sanford C. Bernstein & Co. analyst Nadine Sarwat initiated coverage of three Canadian cannabis stocks on Wednesday but stopped short of any buy recommendations at current levels. “Is the buzz gone...

These cannabis stocks could benefit from adult-use cannabis legalization in Germany

While it’s too early to predict winners and losers among U.S. and Canadian cannabis companies, some of these players are expected to see a boost in sales as Germany moves toward nationwide legalizatio...

Cannabis company that DEA is allowing to grow for research purposes to list shares on Nasdaq

Bright Green Corp., a Fort Lauderdale, Fla.-based company with conditional approval from the U.S. Drug Enforcement Administration (DEA) to produce federally legal cannabis, on Tuesday filed plans to d...

Tilray expected to grow sales sequentially but remain in the red

Tilray Inc. will likely grow its sales over the previous quarter but it’s expected to post a net loss when it becomes the first major cannabis company to post quarterly results in 2022 on Monday. Tilr...